Fluoroquinolones

 

Spectrum

Marbofloxacin

Mycoplasma spp. many Gram-positive and Gram-negative organisms but not anaerobes.

Active against Pasteurella spp. Staphylococcus spp. Pseudomonas spp. Klebsiella spp.

Escherichia coli, Salmonella spp. and Proteus spp.5

 

Enrofloxacin

Mycoplasma spp. many Gram-positive and Gram-negative organisms but not anaerobes.

Active against Pasteurella spp. Staphylococcus spp. Pseudomonas spp. Klebsiella spp.

Escherichia coli, Salmonella spp. Proteus spp. and Mycobacterium spp.5

 

Pradofloxacin

Gram-negative and Gram-positive organisms, anaerobes, Mycoplasma spp. Rickettsia spp. and Mycobacterium spp.31

 

Physicochemical properties

Highly lipophilic.3

 

Distribution3,4,7

Good distribution. Good at entering the central nervous system (CNS), the prostate and urine.

 

Pharmacokinetics

Antimicrobial

Cmax

Protein
binding

Volume of distribution

Metabolism & elimination

Terminal
half life

Absorption

Tmax

Marbofloxacin

 

 

In dogs:

1.5 µg/ml for oral or S.C. administration.9

AUC(0-24) 13 µg.h/ml in dogs for oral administration.32

In cats:

1.4 µg/ml for oral or S.C. administration.9

<10%.6

In dogs:

1.36L/kg.9

In cats:

1.48 L/kg.9

 

 

Renal and in faeces.6

In dogs:
14 hours.6

In cats:
10 hours.6

 

Close to 100% bioavailability.6

In dogs:
<1 hour for S.C. administration, <2 hours for oral administration.9

In cats:
1-2 hours for oral or S.C administration.9

Enrofloxacin

1.41µg/ml32

AUC(0-24) 8.7 µg.h/ml32

27%25

3-4 L/kg25

Renal and some metabolised to ciprofloxacin by the liver.25

In dogs:
4-5 hours.25

In cats:
6 hours.25

Bioavailability 80%.25

<1 hour25

Pradofloxacin

In dogs: 1.01 µg/ml and

AUC(0–24)  8.19 µg.h/ml.31

In cats following administration of tablets at the dose rate of 3 mg/ kg: 0.83 µg/ml and AUC(0–24)  4.14 µg.h/ml.31

In cats following administration of suspension at the dose rate of 5 mg/kg: 1.45 µg/ml and AUC(0–24) 6.21 µg.h/ml.31

29-37%.31

In dogs:
2.22L/kg.31

In cats:
4.5 L/kg.31

10 and 40% excreted in urine in cat and dog respectively, remainder probably in faeces.31

In dogs:
6.6 hours.31

In cats:
10 hours.31

In dogs almost 100%.6

In cats at least 70%.6

In dogs:
2.1 hours.31

In cats:
0.5–1.0 hours.31

Parameters for oral administration in dogs unless otherwise stated.

 

Side effects/contra-indications85

Side effects and contra-indications may vary between presentations. Some of those seen more frequently are included here but veterinary surgeons should always refer to the Summary of Product Characteristics (SPC) for full details before prescribing a product.

 

Side effects include gastrointestinal disturbances at higher doses.

In cats, some but not all commercially available fluoroquinolones may cause blindness or ocular lesions at higher doses.

In young animals fluoroquinolones can produce arthropathy.

 

Disclaimer:  Indications and doses may vary between products.  The antimicrobials listed may constitute an off licence use of the product and as such should only be used according to the ‘Cascade’, further details of which are available on the RCVS, VMD and NOAH websites.  Veterinary surgeons are advised to carefully check the Summary of Product Characteristics (SPC) before prescribing a product and obtain informed owner consent where required.